IGXT insider filings
IntelGenx Technologies Corp. — 44 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-05-03. Screen IGXT transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for IGXT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — IntelGenx Technologies Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-03 | 4 | ATAI Life Sciences N.V. — 10% owner ATAI Life Sciences AG — 10% owner | Other (J) | EDGAR |
| 2024-03-12 | 4 | ATAI Life Sciences N.V. — 10% owner ATAI Life Sciences AG — 10% owner | Other (J): 7,401 (derivative) · Other (J): 8,500,000 (derivative) · Purchase (P): 750,000 (derivative) · Purchase (P): 4,053,750 (derivative) · Other (J): 1,000,000 (derivative) · Other (J): 4,000,000 (derivative) | EDGAR |
| 2024-01-31 | 4 | Kenny Tommy — SVP IP Legal Affairs Subsid | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 95,648 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Nawacki Mark — Director | Grant/award (A): 111,783 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Pourhassan Zenoz Nina — VP, Quality Operations of Subs | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 67,682 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Melchers Bernd Josef — Director | Grant/award (A): 111,783 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Paiement Nadine — VP R & D of IntelGenx Corp. | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 96,206 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Mayr Clemens — Director | Grant/award (A): 92,510 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Zerbe Horst G — Director | Grant/award (A): 107,435 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Godin Andre — President and CFO | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 163,968 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Gorham Dwight — CEO | Grant/award (A): 182,186 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Kalayajian Karen — VP, Finance & Admin of Subs. | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 97,925 (derivative) @ $0 | EDGAR |
| 2023-09-05 | 4 | ATAI Life Sciences N.V. — 10% owner ATAI Life Sciences AG — 10% owner | Purchase (P) · Purchase (P): 11,999,100 (derivative) | EDGAR |
| 2023-04-10 | 4 | Godin Andre — President & CFO | Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-04-10 | 4 | Kenny Tommy — VP IP Legal Affairs-Subsidiary | Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Matzen Dana — VP Business & Corp. Dev | Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Kenny Tommy — VP IP Legal Affairs-Subsidiary | Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Paiement Nadine — VP R & D, IntelGenx Corp. | Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Godin Andre — President & CFO | Grant/award (A): 33,750 (derivative) @ $0 · Grant/award (A): 33,750 (derivative) @ $0 · Grant/award (A): 33,750 (derivative) @ $0 · Grant/award (A): 33,750 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Zerbe Ingrid — Corporate Secretary | Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Zerbe Horst G — Chief Executive Officer, Director | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-10-03 | 4 | Zerbe Horst G — Chief Executive Officer, Director | Purchase (P): 5,000 @ $0.13 · Purchase (P): 14,000 @ $0.12 | EDGAR |
| 2022-10-03 | 4 | Godin Andre — President and CFO | Purchase (P): 5,000 @ $0.12 | EDGAR |
| 2022-09-29 | 4 | Godin Andre — President and CFO | Purchase (P): 1,000 @ $0.13 · Purchase (P): 9,000 @ $0.14 | EDGAR |
| 2022-09-28 | 4 | Kenny Tommy — VP IP Legal Affairs-Subsidiary | Purchase (P): 19,000 @ $0.14 | EDGAR |
| 2022-09-26 | 4 | Kenny Tommy — VP IP Legal Affairs-Subsidiary | Purchase (P): 23,500 @ $0.14 · Purchase (P): 2,000 @ $0.15 · Purchase (P): 8,000 @ $0.15 | EDGAR |
| 2022-09-22 | 4 | Godin Andre — President and CFO | Purchase (P): 20,000 @ $0.13 | EDGAR |
| 2022-09-22 | 4 | Matzen Dana — VP BD & Corp.Dev.of Subsidiary | Purchase (P): 25,000 @ $0.14 | EDGAR |
| 2022-07-08 | 4 | Godin Andre — President and CFO | Other (J): 71,123 @ $0.22 · Other (J): 2,105 @ $0.30 · Other (J): 20,000 (derivative) @ $0 | EDGAR |
| 2022-07-08 | 4 | Zerbe Ingrid — Corporate Secretary | Other (J): 355,618 @ $0.22 · Other (J): 10,526 @ $0.30 · Other (J): 100,000 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4 | Matzen Dana — VP BD & Corp.Dev.of Subsidiary | Purchase (P): 25,000 @ $0.27 | EDGAR |
| 2021-06-11 | 4 | Matzen Dana — VP BD & Corp.Dev.of Subsidiary | Purchase (P): 10,000 @ $0.48 | EDGAR |
| 2021-04-13 | 4 | Matzen Dana — VP BD & Corp Dev of Subsidiary | Purchase (P): 25,000 @ $0.49 | EDGAR |
| 2021-04-09 | 4 | Kenny Tommy — VP IP Legal Affairs-Subsidiary | Purchase (P): 11,000 @ $0.44 · Purchase (P): 7,000 @ $0.45 · Purchase (P): 2,000 @ $0.46 | EDGAR |
| 2021-04-07 | 4 | Godin Andre — President and CFO | Purchase (P): 20,000 @ $0.44 | EDGAR |
| 2021-04-06 | 4 | Boudreau Bernard — Director | Purchase (P): 12,500 @ $0.40 · Purchase (P): 12,500 @ $0.47 | EDGAR |
| 2021-01-07 | 4 | Zerbe Ingrid — Corporate Secretary | Other (J): 11,940 @ $0.26 · Sale (S): 500 @ $0.24 | EDGAR |
| 2021-01-07 | 4 | Godin Andre — President and CFO | Other (J): 2,388 @ $0.26 | EDGAR |
| 2020-11-24 | 4 | Godin Andre — President & CFO | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2020-11-24 | 4 | Matzen Dana — VP Bus. Dev., IntelGenxCorp. | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-11-24 | 4 | Paiement Nadine — VP R & D, IntelGenx Corp. | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-11-24 | 4 | Zerbe Horst G — Chief Executive Officer, Director | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2020-11-24 | 4 | Obeid Rodolphe — VP Operations, IntelGenx Corp. | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-08-25 | 4 | Godin Andre — President and CFO | Holdings only — no transactions reported | EDGAR |
Recent 8-K events — IntelGenx Technologies Corp.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-02-28 | 8-K | 1.03 — Bankruptcy or Receivership 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2024-10-07 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-07-23 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-06-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-05-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-03-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-14 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IGXT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs